Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 264

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases

Open access
Wood, Bradford J., Abraham, Jame, Hvizda, Julia L., Alexander, H. Richard, Fojo, Tito·2003·Cancer

Abstract

BACKGROUND: The current study was performed to analyze the feasibility, safety, imaging appearance, and short‐term efficacy of image‐guided percutaneous radiofrequency ablation (RFA) of primary and metastatic adrenal neoplasms including adrenocortical carcinoma. METHODS: The procedure was performed using 36 treatment spheres on 15 adrenocortical carcinoma primary or metastatic tumors in eight patients over 27 months. Tumors ranged from 15 to 90 mm in greatest dimension with a mean of 43 mm. All patients had unresectable tumors or were poor candidates for surgery. Mean follow‐up was 10.3 months. RESULTS: All patients were discharged or were free of procedure‐related medical care 6–48 hours after the procedures without major complications. All treatments resulted in presumptive coagulation necrosis by imaging criteria, which manifested as loss of previous contrast enhancement in ablated tissue. Eight of 15 (53%) posttreatment thermal lesions lost enhancement and stopped growing on latest follow‐up computed tomographic scan. Three of 15 (20%) demonstrated interval growth and four did not change in size. Of these four lesions, two showed contrast enhancement. For smaller tumors with a mean greatest dimension less than or equal to 5 cm, 8 of 12 (67%) tumors were completely ablated, as defined by decreasing size and complete loss of contrast enhancement. Three of 15 (20 %) tumors and related thermal lesions were found to have disappeared nearly completely on imaging. CONCLUSIONS: Percutaneous, image‐guided RFA is a safe and well tolerated procedure for the treatment of unresectable primary or metastatic adrenocortical carcinoma. The procedure is effective for the short‐term local control of small adrenal tumors, and is most effective for tumors less than 5 cm. The survival rate for patients with adrenocortical carcinoma improves when radical excision is performed in selected patients. Aggressive local disease control may potentially influence survival as well. However, further study is required to evaluate survival impact, document long‐term efficacy, and to determine if RFA can obviate repeated surgical intervention in specific clinical scenarios. Cancer 2003;97:554–60. Published 2003 by the American Cancer Society. DOI 10.1002/cncr.11084

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.11084

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 264

Metadata

Authors
Wood, B. J., Abraham, J., Hvizda, J. L., Alexander, H. R., & Fojo, T.
Venue
Cancer
Publisher
Wiley
Published
2003-01-17
Volume
97
Issue
3
Pages
554-560
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2117631910
Cited by
264
References
20
FWCI
12.85
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. https://app.cochat.ai/papers/10.1002/cncr.11084
The paper
Wood, B. J., Abraham, J., Hvizda, J. L., Alexander, H. R., & Fojo, T. (2003). Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer. https://doi.org/10.1002/cncr.11084

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.